Page last updated: 2024-08-21

aminoimidazole carboxamide and Brain Injuries, Traumatic

aminoimidazole carboxamide has been researched along with Brain Injuries, Traumatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dash, PK; Hill, JL; Hylin, MJ; Kobori, N; Moore, AN; Rozas, NS; Zhao, J	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Brain Injuries, Traumatic

Article	Year
Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome. Journal of neurochemistry, 2016, Volume: 139, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain Injuries, Traumatic; Enzyme Activators; Hippocampus; Male; Maze Learning; Memory Disorders; Metformin; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nootropic Agents; Parietal Lobe; Phosphorylation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribonucleotides	2016

Article

Year

Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome.

Journal of neurochemistry, 2016, Volume: 139, Issue:1

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain Injuries, Traumatic; Enzyme Activators; Hippocampus; Male; Maze Learning; Memory Disorders; Metformin; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nootropic Agents; Parietal Lobe; Phosphorylation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribonucleotides

2016